Pediatric Neck Imaging Guidelines — Clinical Coverage and Prior Authorization Guidance
Customize your policy alerts
Sign up for all evicore policy alerts
Know when evicore releases new policies or updates existing guidance.
Monitor payer policy activity
Clinical coverage and appropriate-use guidance for imaging of the pediatric neck (≤18 years) including modality-specific recommendations and associated CPT procedure codes; applies to health benefit plans administered by Cigna and used by eviCore for determination of medical necessity.
No material clinical or coverage changes in this revision.
Coverage Criteria and Clinical Guidance
General Guidelines
Covered when ALL of the following general prerequisites are met:
Documentation should be in the record and available for prior authorization review.
Imaging is limited to individuals with documented active clinical signs or symptoms of neck disease.
Frequency limits may be specified in condition-specific sections.
MRI General Considerations
MRI-specific considerations (apply when MRI is being requested):
Limit gadolinium use to situations where contrast adds necessary diagnostic information; consider cumulative exposure.
When sedation/IV access is required, consider obtaining both non-contrast and contrast sequences in the same session to avoid repeat sedation.
Coordinate with imaging service to optimize study selection and sequences.
CT General Considerations
CT-specific considerations (apply when CT/CTA is being requested):
Limit exam region for follow-up studies to reduce radiation exposure when clinically appropriate.
Be aware iodine-based contrast can affect subsequent radioactive iodine therapies; prefer MRI when avoidance of iodine is important.
CTA Neck (CPT 70498) is indicated specifically for vascular concerns.
Coordinate imaging choice with clinical team to limit region scanned on follow-up exams.
Ultrasound General Considerations
Ultrasound-specific considerations (apply when ultrasound is being requested):
Ultrasound is preferred because it avoids radiation and sedation and is widely available.
If ultrasound fully defines the diagnosis (e.g., positive infant torticollis), further advanced imaging may be unnecessary.
Neck Masses (Pediatric) - Indications and modality selection
Covered when meeting the indicated clinical scenarios below:
Color Doppler/vascular ultrasound (CPT 93880 or 93882) is indicated when vascular assessment is needed.
Select MRI versus CT based on need for soft tissue detail, need to avoid radiation or iodine, and sedation considerations.
Document clinical findings supporting suspicion for malignancy.
If concern for abscess or complication, escalate per Cervical Lymphadenopathy criteria.
For ranula (plunging lesion) prefer CT Neck with contrast or MRI with and without contrast.
Cervical lymphadenopathy — initial and advanced imaging
Covered when ALL/ANY of the following condition-specific criteria are met:
If there is improvement with conservative treatment, advanced imaging is not medically necessary.
Document duration and response to therapy in the record.
Select modality based on extent, suspected suppuration, and need for surgical planning.
Document systemic features prompting oncology referral.
Torticollis — infants and children/adults
Covered when ANY of the following age- and context-specific criteria are met:
Ultrasound defines the diagnosis in most infant cases; further imaging only if unclear or atypical presentation.
High-risk mechanisms include major motor vehicle collisions, falls from height, pedestrian struck, etc.; document mechanism of injury.
Choose modality based on suspected etiology and need to avoid sedation or radiation.
Dysphagia — Initial Imaging
Covered initial imaging for dysphagia and suspected foreign body:
Plain films are effective for detecting radiopaque foreign bodies and other pathologic findings; document clinical concern.
Dysphagia — Motility Testing
Covered when ALL of the following motility-related criteria are met:
Use when clinical history and symptoms suggest a motility disorder rather than an isolated structural foreign body.
Thyroid Masses, Nodules, and Preoperative Imaging
Covered when meeting the indicated thyroid/parathyroid clinical pathways:
Ultrasound is the preferred first-line modality for thyroid evaluation in pediatric individuals.
Documentation should include TSH result and ultrasound findings to justify FNA; repeat FNA per surveillance rules if initial sample inadequate.
Radioactive iodine uptake imaging is reserved when diagnosis remains unclear after ultrasound and laboratory evaluation.
Be aware iodinated contrast may suppress radioactive iodine uptake; consider MRI if avoidance of iodine is clinically important.
Thyroid Nodule Surveillance
Follow-up surveillance timing for thyroid nodules (apply to pediatric nodules):
Document prior biopsy result to justify timing.
Benign nodules that have been surgically resected do not require routine imaging follow-up absent clinical or laboratory changes.
Hypothyroidism imaging
Covered when ALL of the following apply for hypothyroidism evaluation:
For documented congenital hypothyroidism, thyroid uptake nuclear imaging (CPT 78012 or 78014) is medically necessary after initial ultrasound and laboratory evaluation.
Parathyroid imaging
Covered when ALL parathyroid indications align with standard adult criteria:
Document clinical and laboratory indications prompting parathyroid imaging.
Esophagus imaging
Esophageal imaging indications specific to pediatric patients — covered when any of the following are met:
Document the ingestion event or clinical suspicion; plain films are first-line for radiopaque objects.
Esophagram is the preferred study for demonstrating fistula communication during nasogastric tube contrast injection.
Plain radiographs often suffice for initial diagnosis of esophageal atresia; reserve CT for cases where further anatomic detail is required.
Trachea and foreign body imaging criteria
Covered when indications for airway/tracheal imaging or suspected foreign body are met:
3D rendering (CPT 76376/76377) may be medically necessary for preoperative planning in complex cases.
Chest x-ray is the usual initial study (sensitivity 62–88%); CT has reported sensitivity and specificity >92% and high diagnostic accuracy for airway foreign bodies.
Advanced imaging (CT, MRI, nuclear medicine) is intended for individuals with documented active clinical signs or symptoms of neck disease and is not medically necessary for routine screening of asymptomatic pediatric individuals unless a specific guideline section states otherwise. Prior to advanced imaging, a pertinent clinical evaluation (history, physical exam, relevant laboratory studies, or meaningful technological contact) should be performed unless following guideline-supported scheduled follow-up imaging.
Uncomplicated lymph node enlargement following a typical viral or bacterial infection does not require advanced imaging. Painful acute lymphadenopathy should receive a trial of conservative therapy (including antibiotics if appropriate) for at least 4 weeks; if there is clinical improvement after conservative care, further advanced imaging is not medically necessary.
When ultrasound in infants with suspected congenital muscular torticollis is diagnostic (i.e., a positive ultrasound defining the diagnosis), no further advanced imaging is medically necessary. CT or MRI are only indicated if the ultrasound is negative or additional structural evaluation is required.
Be aware that iodinated (CT) contrast can suppress radioactive iodine uptake and may delay radioiodine treatment; when avoidance of iodinated contrast is clinically important (for example prior to planned radioactive iodine therapy), consider MRI as the preferred cross‑sectional modality.
For suspected esophageal atresia, plain radiographs are usually sufficient for diagnosis and are the medically necessary initial study; contrast esophagram is not routinely warranted except when specifically needed for postoperative evaluation.
When evaluating mediastinal or deep soft‑tissue concerns, CT is generally preferred over MRI because of wider availability, faster acquisition, and lower cost. MRI remains valuable for soft‑tissue characterization or when avoiding iodinated contrast is important, but CT is favored for expediency and mediastinal evaluation.
Repeat advanced imaging of the neck is not medically necessary in the absence of documented disease progression, new clinical findings, or clear documentation that repeat imaging will affect management or treatment decisions.
When concern for malignancy exists, ordering MRI or CT does not require a prior ultrasound. Ultrasound should not be mandated before advanced imaging when clinical findings raise suspicion for malignancy; obtain the modality most appropriate to the clinical question.
For painful acute lymphadenopathy, providers should document a trial of conservative therapy for at least 4 weeks (including antibiotics if appropriate) before pursuing advanced imaging. If clinical improvement is demonstrated during that period, advanced cross‑sectional imaging is not medically necessary; ultrasound remains the first‑line imaging when persistent or concerning features are present.
Benign thyroid nodules that have been surgically resected do not require routine imaging follow‑up unless there are new clinical or laboratory findings suggesting recurrence. Surveillance ultrasound intervals after biopsy should follow the specified timing (for example 3–6 months for inadequate biopsy, 6–12 months for benign/ stable nodules, then every 1–2 years if stable).
Radioactive iodine uptake (thyroid scintigraphy) should be reserved for situations where the diagnosis remains unclear after ultrasound and laboratory evaluation. Use uptake imaging (e.g., CPT 78012/78014/78013) only when ultrasound and TSH/related labs do not establish the etiology of hyperthyroidism or nodular function.
Indications Where Imaging Is Medically Necessary
Modality selection based on clinical question
Match modality to the clinical question — use the modality most likely to answer the diagnostic question with least risk:
Use ultrasound to guide need for further advanced imaging when results are inconclusive.
Obtain non-contrast and contrast sequences in same sedation session when IV access is required.
Consider radiation-minimizing techniques and documented contraindications to contrast.
Initial evaluation of pediatric neck mass
Initial diagnostic pathway for a pediatric neck mass:
Ultrasound preferred for availability, cost, lack of radiation and avoidance of sedation.
Select vascular ultrasound to answer specific vascular questions.
Choose MRI when soft-tissue detail and avoidance of ionizing radiation are priorities; choose CT when rapid acquisition or bone detail is required.
Inconclusive ultrasound or complex lesion characterization
Covered when ultrasound is non-diagnostic or the lesion is complex:
MRI offers superior soft tissue contrast but may require sedation; CT provides rapid acquisition and superior bone detail.
Evaluation of parotid masses for Warthin's tumor
Specific evaluation pathway for suspected Warthin's tumor of the parotid:
Cervical lymphadenopathy — persistent after conservative care
Covered when persistent after conservative care (apply documentation requirements):
Document duration of lymphadenopathy and prior conservative therapy to support imaging request.
Inconclusive ultrasound or complex lesion characterization
When ultrasound is inconclusive or clinical concern persists, escalate imaging:
CT may be preferred for rapid assessment of gas-forming infection or surgical planning; MRI provides soft-tissue contrast.
Evaluation of parotid masses for Warthin's tumor
Specific imaging approach for parotid masses when Warthin's tumor is suspected:
Document reason for nuclear imaging and role in preoperative planning.
Cervical lymphadenopathy — persistent after conservative care
Covered when cervical lymphadenopathy persists after conservative care:
If clinical improvement is documented, advanced imaging is not medically necessary.
Suspected neck abscess/suppurative lymphadenopathy
Covered when managing suspected neck abscess or suppurative lymphadenopathy:
If ultrasound is inconclusive or to evaluate extent, escalate to CT (70491) or MRI (70540/70543).
Congenital muscular torticollis in infants <12 months
Covered initial imaging approach for congenital muscular torticollis in infants <12 months:
If ultrasound is positive, no further imaging is medically necessary; if negative or further evaluation required, escalate to CT (70491) or MRI (70540/70543).
Acquired torticollis with trauma
Covered imaging pathway for acquired torticollis in the setting of trauma:
If radiographs are inconclusive or high-risk mechanism present within prior 3 months, obtain CT Neck with contrast (70491) and/or CT Cervical Spine without contrast (72125).
Document neurologic findings prompting MRI.
Nontraumatic torticollis — evaluation of underlying causes
Covered advanced imaging indications for nontraumatic torticollis:
Select modality based on likely etiology and need to avoid sedation or radiation.
Suspected foreign body ingestion
Initial imaging required for suspected foreign body ingestion:
Failure to obtain initial plain films may lead to non-authorization of advanced imaging.
Anatomic variants causing dysphagia (vascular ring/right aortic arch)
Covered when chest radiograph suggests vascular anomaly causing dysphagia:
Select CTA versus MRA based on urgency, need for vascular detail, and contraindications to contrast or sedation.
Thyroid masses/nodules
Covered initial approach for thyroid masses/nodules:
Ultrasound is sensitive, noninvasive, and does not require sedation.
Hyperthyroidism with unclear etiology after ultrasound and labs
Covered when hyperthyroidism remains unclear after initial evaluation:
Radioactive iodine uptake scans are reserved and only medically necessary after ultrasound and lab evaluation are inconclusive.
Preoperative planning or suspected substernal extension
Covered indications for preoperative imaging or suspected substernal extension:
Document clinical findings and prior imaging/lab results; note that iodinated contrast can suppress radioactive iodine uptake when postoperative radioiodine therapy is anticipated.
Thyroid abnormalities
General thyroid imaging guidance:
If nodules or masses are found, follow the Thyroid Masses/Nodules criteria for further management.
Congenital hypothyroidism
Covered specific to congenital hypothyroidism:
Procedure Codes and Coding Guidance
| 70540 | MRI Orbit, Face, Neck without contrast |
| 70542 | MRI Orbit, Face, Neck with contrast |
| 70543 | MRI Orbit, Face, Neck without and with contrast |
| 70336 | MRI Temporomandibular Joint (TMJ) |
| 76498 | Unlisted MRI procedure (for radiation planning or surgical software) |
| 70547 | MRA Neck without contrast |
| 70548 | MRA Neck with contrast |
| 70549 | MRA Neck without and with contrast |
| 70486 | CT Maxillofacial without contrast |
| 70487 | CT Maxillofacial with contrast |
| 76536 | Ultrasound Neck (Ultrasound soft tissues of the neck) |
| 70491 | CT Neck with contrast |
| 76536 | Ultrasound, soft tissues of head and neck (initial / first-line study) |
| 78258 | Esophageal motility study |
| 71275 | CT Angiography (CTA) Chest |
| 71555 | MRA Chest |
| 76536 | Ultrasound, soft tissue of neck |
| 76942 | Ultrasound guidance for needle placement (eg, biopsy) |
| 78013 | Thyroid quantitative scintigraphy (planar), with uptake and imaging |
| 78014 | Thyroid quantitative scintigraphy (uptake only) |
| 78012 | Thyroid uptake study |
| 70490 | CT Neck without contrast |
| 70491 | CT Neck with contrast |
| 76536 | Ultrasound Neck |
| Unlisted | Plain radiographs (general radiography) for foreign body ingestion — specific CPTs not listed in this section |
Prior Authorization, Documentation, and Ordering Expectations
Prior authorization required for listed CPTs
Follow eviCore/Cigna prior authorization processes for the high‑tech imaging CPT codes listed in the guideline; requests for these procedures must follow the payer's prior authorization workflow.
- Applies to the CPT codes enumerated in the policy (e.g., MRI, CT, CTA, MRA, select ultrasound and nuclear CPTs).
- Use eviCore/Cigna prior authorization channels when submitting requests.
Reference guideline indication when requesting neck imaging
When requesting MRI, CT, or select nuclear/ultrasound neck studies, cite the guideline‑specified clinical indication that justifies the modality (e.g., malignancy concern, inconclusive ultrasound, preoperative planning) and include the relevant CPT code(s).
- Reference the applicable clinical criteria from the guideline when submitting authorization requests.
- Include the specific CPT(s) being requested (examples listed in the policy).
Match modality to the indicated clinical criteria
Order the imaging modality that matches the clinical indication: ultrasound (CPT 76536) as initial for superficial/thyroid/parotid lesions; MRI (70540/70543) or CT Neck with contrast (70491) when ultrasound is inconclusive or other criteria are met.
- Match modality to clinical criteria (US first-line for superficial lesions; CT/MRI for trauma, malignancy, preoperative planning or inconclusive US).
Standard prior authorization for medically necessary studies
Standard authorization applies for studies identified as medically necessary (for example ultrasound CPT 76536, ultrasound‑guided FNA CPT 76942, and specified nuclear thyroid CPTs); supply required documentation with the authorization request.
- These studies are subject to routine eviCore prior authorization review.
- Include clinical documentation as described in the guideline to support medical necessity.
Provide supporting documentation for select advanced studies
Supply supporting clinical information when requesting thyroid uptake scans, CT neck/chest with contrast, or 3D rendering (preoperative planning); include prior evaluations and labs to justify these advanced studies.
- Document why prior ultrasound/laboratory evaluation was insufficient when ordering uptake scans.
- Provide clinical/lab data to support CT neck/chest and any request for 3D rendering.
CT Neck/Chest CPTs require indication-specific justification
CT Neck with contrast (CPT 70491) and CT Chest with contrast (CPT 71260) are identified as medically necessary for evaluation of suspected congenital malformations and related indications; when requesting these CPTs include clinical justification per guideline.
Benefit plan document governs coverage and may supersede guideline
Coverage decisions are governed by the terms of the applicable benefit plan document; if the plan excludes imaging or conflicts with the guideline, the benefit plan document prevails and may result in denial.
- Verify the member's benefit plan terms before ordering and submitting authorization.
- Discrepancies between guideline and plan are resolved in favor of the plan document.
Use ultrasound (CPT 76536) as initial study for neck masses
Order ultrasound (CPT 76536) as the initial study of choice for evaluation of neck masses when malignancy is not suspected; if ultrasound defines the diagnosis, no further imaging is medically necessary.
- Ultrasound is preferred prior to advanced imaging for neck masses and infant torticollis.
- If US is positive and defines the diagnosis, additional imaging is not required.
4‑week conservative therapy trial before advanced imaging for painful lymphadenopathy
Start with a trial of conservative therapy (at least 4 weeks, including antibiotics if appropriate) for painful acute lymphadenopathy; advanced imaging is not medically necessary if there is improvement after the 4‑week trial.
- Document a minimum 4‑week trial of conservative care prior to advanced imaging for painful lymphadenopathy.
- If symptoms improve with conservative therapy, do not pursue advanced imaging.
Follow specified ultrasound surveillance intervals after FNA
Adhere to the recommended ultrasound follow‑up intervals after FNA or benign results: repeat ultrasound/FNA 3–6 months for inadequate biopsy, 6–12 months after benign FNA, then every 1–2 years if stable.
- Document biopsy results and timing to support surveillance imaging requests.
- Follow the specified intervals before requesting additional diagnostic procedures.
Uptake scans only after ultrasound and labs are inconclusive
Reserve radioactive iodine uptake imaging for cases where ultrasound and laboratory evaluation are inconclusive; document prior ultrasound and lab results when ordering uptake scans.
- Do not order uptake scans before completing ultrasound and laboratory evaluation unless congenital hypothyroidism is documented.
- Include TSH/lab results and prior ultrasound findings with the authorization request.
Document a pertinent clinical evaluation before advanced imaging
Perform and document a pertinent clinical evaluation (detailed history, physical exam, and appropriate labs or meaningful technological contact) prior to advanced imaging unless guideline‑supported scheduled follow‑up is planned.
- Clinical evaluation may be documented via in‑person exam or meaningful telehealth/telephone/electronic contact.
- Include onset/change in symptoms and relevant labs in the record.
Document history, duration, and specific concern for neck masses/lymphadenopathy
Document the clinical history, duration of lymphadenopathy, and the specific clinical concern (e.g., malignancy, congenital cyst, ranula, fourth branchial cleft) to justify modality selection and any additional studies.
- Specify duration (>4 weeks if persistent lymphadenopathy) and signs/symptoms guiding imaging.
- If fourth branchial cleft suspected, document need for barium swallow in addition to imaging.
Document conservative therapy trial and clinical findings for lymphadenopathy
Document a minimum 4‑week trial of conservative therapy for painful acute lymphadenopathy (including antibiotics if appropriate) and include clinical findings that guide use of ultrasound, CT, or MRI.
- Record duration and response to conservative care in the chart and authorization request.
- Include fever ≥100.4°F or signs suggesting suppuration if present.
Include TSH and ultrasound findings when requesting FNA or thyroid nuclear studies
When requesting FNA (CPT 76942) or thyroid nuclear imaging (CPTs 78012/78013/78014), include TSH result and ultrasound findings in the documentation to justify the procedure.
- Attach lab results (TSH) and pertinent ultrasound report when seeking authorization for FNA or thyroid scintigraphy.
- For post‑biopsy surveillance include biopsy results and dates.
Document prior imaging/labs and indication for thyroid uptake scans
When ordering thyroid radioactive iodine uptake scans, document the indication, prior imaging and laboratory evaluation, and explain why plain radiographs or ultrasound were insufficient if applicable.
- Document congenital hypothyroidism if ordering uptake imaging for that indication.
- Provide rationale for uptake imaging versus ultrasound where relevant.
Support CT Neck/Chest and 3D rendering requests with clinical justification
Provide documentation supporting the clinical indication (e.g., suspected congenital malformation, complicated case, or when bronchoscopy is being considered) to justify CT Neck/Chest and any 3D rendering (CPT 76376/76377).
- Explain why x‑rays or esophagram were inconclusive before requesting CT and 3D rendering.
- Include specifics of the planned surgical/preoperative need when requesting 3D rendering.
Do not require ultrasound prior to CT/MRI when malignancy suspected
When malignancy is suspected, do not delay advanced imaging by requiring ultrasound first; ordering MRI or CT for concern for malignancy does not require a prior ultrasound.
- Ultrasound is not required prior to MRI/CT when there is clinical concern for malignancy.
- Order the appropriate advanced imaging promptly to evaluate suspected malignancy.
Obtain initial plain x‑rays for suspected foreign body ingestion
Failure to order initial plain radiographs for suspected foreign body ingestion (neck/chest) may lead to non‑authorization of advanced imaging; obtain x‑rays first when appropriate.
- Plain radiographs of neck and chest are medically necessary as initial imaging for suspected foreign body ingestion.
- Include x‑ray findings or rationale if requesting advanced imaging without initial radiographs.
Risk of denial if uptake imaging ordered before ultrasound/labs or without congenital hypothyroidism documentation
Failure to use ultrasound as the initial imaging modality for thyroid abnormalities, or failure to document congenital hypothyroidism when ordering thyroid uptake scans, may result in denied authorization for uptake imaging prior to ultrasound and lab evaluation.
Denial risk for imaging requests lacking guideline‑based justification
Requests for imaging that do not meet the guideline's stated medically necessary indications (for example CT for congenital malformations or complicated cases without supporting documentation) are at risk for denial.
- Ensure documentation demonstrates the specific indication and why less‑advanced studies were insufficient.
- Unsupported CT/3D rendering or other advanced imaging requests may be denied.
Contrast and Preparation Considerations
Use MRI or CT with contrast for further characterization after ultrasound
When further characterization is needed after ultrasound (for abscess, extension, or soft tissue detail), prefer MRI (70540/70543) for soft‑tissue definition and CT Neck with contrast (70491) when appropriate, documenting reasons for modality choice.
Iodinated contrast may suppress radioactive iodine uptake
Be aware that iodinated contrast can suppress radioactive iodine uptake and may delay radioiodine treatment; when planning thyroid uptake imaging or therapy, consider and document contrast implications and alternative imaging (e.g., MRI).
Repeat Imaging and Surveillance Intervals
Prior Authorization Requirements
Prior authorization applies to listed high‑tech imaging CPTs
High‑tech imaging procedures listed in the guideline (MRI, CT, CTA, MRA, etc.) are subject to Cigna/eviCore prior authorization processes when requested; include the guideline clinical indication in submissions.
Cite guideline clinical indication for MRI/CT/nuclear requests
Requests for MRI, CT, or nuclear medicine should cite the specific clinical indication per the guideline (e.g., suspicion for malignancy, inconclusive ultrasound, preoperative planning) when seeking authorization.
Authorization required for all listed advanced modalities
All listed advanced imaging modalities are subject to standard authorization processes when requested; include relevant clinical documentation to support medical necessity.
Documentation recommended for thyroid uptake, CT, and 3D rendering
Thyroid uptake nuclear imaging, CT Neck/Chest, and 3D rendering are medically necessary only for specific documented indications; provide supportive prior clinical and laboratory information with authorization requests.
Key Definitions and Terms
Background and Scope
These pediatric neck imaging guidelines prioritize use of advanced imaging for patients with active, documented clinical signs or symptoms. Screening asymptomatic children with CT, MRI, or nuclear studies is not covered unless a specific guideline section explicitly permits it; coverage decisions should reflect the applicable benefit plan terms.
Not Covered / Exclusions
Screening imaging in asymptomatic pediatric individuals for neck disorders is generally not covered by this guideline. Exceptions only apply where a specific guideline section explicitly indicates otherwise; providers should review the applicable guideline section and benefit plan terms before ordering screening studies.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.